Elravie Re2O is Humedix’s human acellular dermal matrix (hADM) skin booster: 150 mg of freeze-dried human dermal tissue processed by L&C Bio’s Alloclean Technology, which removes cells while preserving the extracellular-matrix structure. Launched in Korea in November 2024 as the first hADM product in the skin-booster market, it is reconstituted and injected to replenish the dermal matrix of the full face and neck for pores, texture and density. Room-temperature storage until opened; professional use only.
What is Elravie Re2O?
Elravie Re2O is a new category of Korean skin booster: 150 mg of freeze-dried human acellular dermal matrix (hADM), launched by Humedix (Huons Group) in November 2024 and described by the company as the first hADM-based product in the skin-booster market. The tissue is processed by L&C Bio using its Alloclean Technology, which removes cells and immunogenic factors while preserving the dermis’s three-dimensional structure, so the product supplies the skin with extracellular-matrix components rather than a single active. Humedix classifies it as a human-tissue product for restoring physiological function.
How is an hADM booster different from PN, HA or collagen boosters?
Polynucleotide products such as Rejuran Healer signal repair; HA boosters hydrate; recombinant collagen products such as Puri Coll Rh add one matrix protein. Re2O supplies the dermal matrix itself — the structural scaffold the skin’s own cells work within. Humedix markets it as an ECM supplement for dermal reconstruction, with pores, blemishes, texture and density as the claimed targets. The 150 mg unit covers the full face and neck; the 50 mg Re2O Fine is aimed at the under-eye and neck lines.
| Elravie Re2O | hADM 150 mg · full face and neck · ECM replenishment |
|---|---|
| Elravie Re2O Fine | hADM 50 mg · under-eye and neck lines |
| Puri Coll Rh | Recombinant collagen I + III 15 mg + HA + PDRN · 2.5 mL |
| Rejuran Healer | Polynucleotide · 2 × 2 mL · dermal repair |
What do clinics use Elravie Re2O for?
Humedix positions it for fundamental skin regeneration of the full face and neck — pore refinement, blemish and texture improvement and increased dermal density — by injecting reconstituted ECM into the dermis. The manufacturer does not publish a fixed diluent volume, needle choice or session count; reconstitution and technique follow the product instructions and the treating clinician’s judgement. Suitability is always assessed by the clinician.
Commonly selected for
- Skin-density and texture programmes for mature skin
- Pore and blemish improvement on the face
- Neck skin quality
- Practices wanting a premium, non-HA regenerative offering
How is Elravie Re2O supplied and stored?
One 150 mg freeze-dried unit per box, reconstituted before use. Store at room temperature (1–30 °C) until the package is opened, per Humedix. As a human-tissue product it is supplied for professional use only.
Reviewed against publicly available manufacturer information. Indications, dosing and technique are product-specific per the manufacturer’s labeling and are decided by the treating clinician.
Specifications
| Brand | Elravie® Re2O (Humedix) |
|---|---|
| Distributor / brand owner | Humedix Co., Ltd. — Huons Group (South Korea) |
| Tissue processor | L&C Bio Co., Ltd. (South Korea), Alloclean Technology |
| Origin | South Korea |
| Active | Human acellular dermal matrix 150 mg |
| Format | Freeze-dried unit in syringe |
| Presentation | 1 unit per box |
| Areas | Full face · neck |
| Classification | Supplied in Korea as a human-tissue product |
| Administration | By a qualified medical professional only; reconstitution and technique per the product instructions |
| Storage & handling | Room temperature 1–30 °C until opened (manufacturer) |
| Composition | Human acellular dermal matrix (hADM) 150 mg, freeze-dried human tissue |
Frequently asked questions
What is Elravie Re2O?
A skin booster made of 150 mg freeze-dried human acellular dermal matrix — decellularised human dermis that supplies the skin with extracellular-matrix components, distributed by Humedix (Huons Group) and processed by L&C Bio.
What is it used for?
Humedix positions it for skin regeneration of the full face and neck: pore refinement, blemish and texture improvement and increased dermal density.
How is it different from Rejuran or an HA booster?
Rejuran is a polynucleotide that signals repair and HA boosters hydrate; Re2O supplies the dermal matrix scaffold itself as an ECM supplement.
How is it prepared and injected?
The freeze-dried 150 mg unit is reconstituted before injection into the dermis. Humedix does not publish a fixed diluent volume or session count; the treating clinician follows the product instructions.
How should Elravie Re2O be stored?
At room temperature between 1 and 30 °C until the package is opened, per the manufacturer. One unit per box.